Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000007154 | SCV001200178 | uncertain significance | Mosaic variegated aneuploidy syndrome 1 | 2022-07-05 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects BUB1B function (PMID: 20516114, 25502805). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 6761). This missense change has been observed in individual(s) with mosaic variegated aneuploidy (MVA) and embryonal rhabdomyosarcoma of the soft palate (PMID: 9916837, 15475955, 18548531). This variant is present in population databases (rs28989181, gnomAD 0.004%). This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 844 of the BUB1B protein (p.Leu844Phe). |
Fulgent Genetics, |
RCV002504759 | SCV002815641 | uncertain significance | Mosaic variegated aneuploidy syndrome 1; Premature chromatid separation trait; Colorectal cancer | 2022-01-10 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000007154 | SCV000027350 | pathogenic | Mosaic variegated aneuploidy syndrome 1 | 2004-11-01 | no assertion criteria provided | literature only | |
OMIM | RCV000007155 | SCV000027351 | affects | Premature chromatid separation trait | 2004-11-01 | no assertion criteria provided | literature only |